Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements
John N. Snouwaert,
No information about this author
Leigh A. Jania,
No information about this author
Trang Thi Huyen Nguyen
No information about this author
et al.
PLoS Pathogens,
Journal Year:
2023,
Volume and Issue:
19(2), P. e1011168 - e1011168
Published: Feb. 22, 2023
Angiotensin-converting
enzyme
2
(ACE2),
part
of
the
renin-angiotensin
system
(RAS),
serves
as
an
entry
point
for
SARS-CoV-2,
leading
to
viral
proliferation
in
permissive
cell
types.
Using
mouse
lines
which
Ace2
locus
has
been
humanized
by
syntenic
replacement,
we
show
that
regulation
basal
and
interferon
induced
ACE2
expression,
relative
expression
levels
different
transcripts,
sexual
dimorphism
are
unique
each
species,
differ
between
tissues,
determined
both
intragenic
upstream
promoter
elements.
Our
results
indicate
higher
observed
lungs
mice
humans
may
reflect
fact
drives
populous
airway
club
cells
while
human
alveolar
type
(AT2)
cells.
In
contrast
transgenic
is
expressed
ciliated
under
control
FOXJ1
promoter,
expressing
endogenous
a
robust
immune
response
after
infection
with
rapid
clearance
virus.
This
supports
model
differential
determines
types
lung
infected,
this
turn
modulates
host
outcome
COVID-19.
Language: Английский
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4
Viruses,
Journal Year:
2024,
Volume and Issue:
16(1), P. 82 - 82
Published: Jan. 4, 2024
Coagulation
disorders
are
described
in
COVID-19
and
long
COVID
patients.
In
particular,
SARS-CoV-2
infection
megakaryocytes,
which
precursors
of
platelets
involved
thrombotic
events
COVID-19,
and,
rare
cases,
vaccinated
individuals,
requires
further
investigation,
particularly
with
the
emergence
new
variants.
CD147,
regulation
inflammation
required
to
fight
virus
infection,
can
facilitate
entry
into
megakaryocytes.
MCT4,
a
co-binding
protein
CD147
key
player
glycolytic
metabolism,
could
also
play
role
infection.
Here,
we
investigated
susceptibility
megakaryocytes
via
MCT4.
We
performed
Dami
cells
human
CD34+
hematopoietic
progenitor
induced
megakaryocytic
differentiation
pseudovirus
presence
AC-73
syrosingopine,
respective
inhibitors
MCT4
inducers
autophagy,
process
essential
megakaryocyte
differentiation.
Both
syrosingopine
enhance
autophagy
during
but
only
enhances
maturation.
Importantly,
found
that
or
significantly
inhibits
Altogether,
our
data
indicate
as
be
used
prevent
binding
COVID-19-associated
coagulopathy.
Language: Английский
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
Cara O'Mahoney,
No information about this author
Ian N. Watt,
No information about this author
Sebastian Fiedler
No information about this author
et al.
Annals of Biomedical Engineering,
Journal Year:
2024,
Volume and Issue:
52(6), P. 1653 - 1664
Published: March 8, 2024
Abstract
SARS-CoV-2
has
rampantly
spread
around
the
globe
and
continues
to
cause
unprecedented
loss
through
ongoing
waves
of
(re)infection.
Increasing
our
understanding
protection
against
infection
with
is
critical
ending
pandemic.
Serological
assays
have
been
widely
used
assess
immune
responses,
but
secretory
antibodies,
essential
first
line
defense,
studied
only
a
limited
extent.
Of
particular
interest
importance
are
neutralizing
which
block
binding
spike
protein
human
receptor
angiotensin-converting
enzyme-2
(ACE2)
thus
for
defense.
Here,
we
employed
Microfluidic
Diffusional
Sizing
(MDS),
an
immobilization-free
technology,
characterize
antibody
affinity
receptor-binding
domain
(RBD)
trimer
in
saliva.
Affinity
measurement
was
obtained
contrived
sample
buffer
using
recombinant
RBD
monoclonal
antibody.
Limited
saliva
samples
demonstrated
that
MDS
applies
measurement.
The
ability
disrupt
complex
ACE2-Fc
shown.
Using
quantitative
assay
on
patient
sample,
determined
site
concentration
antibodies.
Language: Английский